Estimating the benefits of mammography screening: The impact of study design

Epidemiology

Volumn 18, Issue 4, 2007, Pages 487-492

  Olsen, Anne Helene ^a   Njor, Sisse H ^a   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; DATA ANALYSIS; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; BREAST NEOPLASMS; COHORT STUDIES; CONTROL GROUPS; DENMARK; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; POISSON DISTRIBUTION; REPRODUCIBILITY OF RESULTS; RISK;

EID: 34250739074     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318060cbbd     Document Type: Article

References (27)

1. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst. 1988;80:1125-1132.
2. Hakama M, Pukkala E, Heikkilä M, et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ. 1997;314:864-867.
3. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet. 1999;353:1903-1908.
4. Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38:625-651.
5. Miller AB, To T, Baines CJ, et al. Canadian national breast screening study-2:13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92:1490-1499.
6. Miller AB, To T, Baines CJ, et al. The Canadian national breast screening study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-312.
7. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet. 2002;359:909-919.
8. US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Internal Med. 2002;137:344-346.
9. European Union Council. Council Recommendation of 2 December 2003 on Cancer Screening. 2003/878/EC. Bruxelles: European Union Council; 2003.
10. Blanks RG, Moss SM, McGahan CE, et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-1998: comparison of observed with predicted mortality. BMJ. 2000;321:665-669.
11. The Swedish Organized Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography. I. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006;15:45-51.
12. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355:131-136.
13. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358:1340-1342.
14. Njor SH, Olsen AH, Bellstrom T, et al. Mammography screening in the county of Fyn November 1993-December 1999. APMIS. 2003; 111(suppl 110):1-33.
15. Jensen A, Olsen AH, von Euler-Chelpin M, et al. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer. 2005;113:464-470.
16. Törnberg S, Carstensen J, Hakulinen T, et al. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. J Med Screen. 1994;1:184-187.
17. Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330:220-222.
18. Olsen AH, Njor SH, Vejborg I, et al. A model for determining the effect of mammography service screening. Acta Oncol. 2005;44:120-128.
19. Fischerman K, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncol. 1988;27:593-596.
20. Fuglede N, Langballe O, Svendsen AL, et al. Development in incidence of breast cancer in non-screened Danish women, 1973-2002 - a population-based study. Int J Cancer. 2006;118:2366-2369.
21. Andreasen AH, Andersen KW, Madsen M, et al. Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screening. Br J Cancer. 1994;70:133-137.
22. Andreasen AH, Mouridsen HT, Andersen KW, et al. Improved prognosis of breast cancer. Ugeskr Laeg. 1994;156:6512-6517.
23. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
24. Otto SJ, Fracheboud J, Looman CWN, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003;361:1411-1417.
25. Parvinen I, Helenius H, Pylkkanen L, et al. Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen. 2006;13:34-40.
26. Dean P, Pamilo M. Screening mammography in Finland - 1. 5 million examinations with 97 percent specificity. Acta Oncol. 1999;(suppl 13):47-54.
27. Törnberg S, Kemetli L, Lynge E, et al. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol. 2006;45:528-535.